Office of the President

A message from the president:

  • Announcing new Executive Vice President and Provost, Dean of the School of Medicine

    April 4, 2019, 10:18 AM by Stephen Hadley

    I am pleased to announce that, after an extensive national search that provided us an impressive slate of candidates, I have appointed Dr. Charles Mouton to the role of executive vice president and provost, and dean of the School of Medicine. He will assume his new responsibilities Monday, April 8.

    mouton_2018Dr. Mouton has served as dean ad interim for the School of Medicine since August of last year, after joining UTMB in 2017 as vice dean for academic affairs and professor of family medicine.

    Prior to UTMB, Dr. Mouton held a number of leadership and faculty roles at Meharry Medical College, including senior vice president for health affairs and dean of medicine from 2010 to 2014. He earned his medical degree from Howard University College of Medicine, a Master of Science in clinical epidemiology from Harvard University School of Public Health and a Master of Business Administration from Tennessee Technological University.

    Dr. Mouton has also served at Howard University College of Medicine, the University of Texas Health Science Center at San Antonio and the University of Medicine and Dentistry of New Jersey. He has been appointed to numerous national committees throughout his career, including his current service on the National Institutes of Health Council of Councils—a 27-member panel that advises the NIH director.

    An experienced and collaborative physician, scientist, educator and leader, Dr. Mouton is well-versed in the need for research and clinical priorities to align for the good of those we serve. And, he has a vision for how UTMB can break new ground in training the next generation of caregivers and scientists to work in interprofessional teams and with emerging technology to meet the evolving needs of patients. I am confident that, under his skilled leadership, our academic enterprise will continue to progress and flourish.

    I want to take this opportunity to thank Dr. Anish Bhardwaj for his service as provost ad interim. We greatly appreciate his steadfast leadership during this transition, and we look forward to continuing to work with him as professor and chair of neurology and vice provost for faculty affairs and professional development.

    I am also grateful to the search committee, which was chaired by Donna Sollenberger, executive vice president and CEO of our Health System, and Dr. David Niesel, senior vice president and dean of the Graduate School of Biomedical Sciences. The input of the committee and others involved in the interview process was most valuable in this important decision, and I appreciate everyone’s time and commitment to the search.

    Please join me in thanking Dr. Bhardwaj and in congratulating Dr. Mouton on his new role. This is an exciting time for our academic enterprise and our entire university, and I look forward to working with everyone at UTMB to define what comes next in health care.

    Thank you.

    Dr. David L. Callender

  • UTMB's burn research program

    January 17, 2019, 17:11 PM by Stephen Hadley

    I want to let the UTMB community know about a developing situation regarding our burn research program.

    In late April 2018, UTMB received several allegations regarding possible research compliance issues with burn patients.

    The allegations involved possible inappropriate treatment provided by UTMB faculty members and staff for burn patients enrolled in human subject research studies at Shriners Burns Hospital for Children-Galveston.

    Based on these concerns, UTMB’s Institutional Review Board (IRB) immediately suspended research activities associated with three burn research protocols.

    At that time, working with Shriners Hospitals, UTMB launched a comprehensive investigation spanning burn research at UTMB and Shriners Burns Hospital-Galveston. Based on the initial findings of this investigation, clinical burns research activities at UTMB and at the Shriners facility in Galveston were suspended.

    Given the complexity of the situation, UTMB has engaged a specialized consulting firm to review identified areas of concern and to help develop a corrective action plan to ensure that, going forward, all research involving Shriners Burns Hospital-Galveston and UTMB consistently meets or exceeds all applicable standards. This work is in process. All burns research will remain suspended during this review.

    As required, UTMB has notified federal agencies involved in oversight of human subject research and investigational new drugs and is working to schedule additional discussions with those agencies.

    UTMB is committed to protecting the rights, safety and well-being of its participants in research studies and will continue to enhance safeguards to ensure this commitment is fulfilled.

    An update for the UTMB community will be provided as we are able.

    Thank you.

    Dr. David L. Callender

    CLARIFICATION: The statement, “All burns research will remain suspended during this review,” in this message refers only to clinical research (projects involving human subjects). Basic research projects related to burns have not been suspended.

Contact Information

Office of the President
(409) 772-1902 
(409) 772-5064 fax

Suite 6.100 Administration Bldg.
301 University Blvd.
Galveston, Texas 77555-0129

UTMB Maps & Directions